Lucanthone is an endonuclease inhibitor of Apurinic endonuclease-1 (APE-1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133 | |
2 mg | In stock | $ 239 | |
4 mg | In stock | $ 378 | |
10 mg | In stock | $ 644 | |
20 mg | In stock | $ 966 |
Description | Lucanthone is an endonuclease inhibitor of Apurinic endonuclease-1 (APE-1). |
In vitro | Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. To investigate the anticancer activity of Lucanthone, cell viability is measured by MTT assay. Lucanthone reduces cell viability to a similar extent in a panel of seven breast cancer cell lines. In addition, a direct comparison reveals that Lucanthone is significantly more potent than Chloroquine (CQ) at reducing breast cancer cell viability with a mean IC50?of 7.2 μM versus 66 μM for CQ. Measurement of cell viability in two representative cell lines (MDA-MB-231 and BT-20) by ATPlite assay and trypan blue exclusion reveals comparable results. |
Synonyms | Lucantona, Lucanthonum |
CAS No. | 479-50-5 |
Chemical Formula | C20H24N2OS |
Molecular Weight | 340.49 |
Solubility | DMSO: 25 mg/mL), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom